SCHEMBL24299591

SCHEMBL24299591

N#Cc1cc(OC2CCNCC2)ccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HRH1 P35367 3/20 0.46
PGR P06401 2/20 0.46
IKBKB O14920 1/20 0.45
P2RX7 Q99572 1/20 0.43
ROCK1 Q13464 2/20 0.43
ROCK2 O75116 1/20 0.43
PRKACA P17612 1/20 0.43
PRKCD Q05655 1/20 0.43
PRKG1 Q13976 1/20 0.43
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
CDC42BPA Q5VT25 1/20 0.43
Q6ZSR9 Q6ZSR9 1/20 0.43
BMP2K Q9NSY1 1/20 0.43
CDC42BPB Q9Y5S2 1/20 0.43
ALK Q9UM73 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4969971 0.88 PGR (0.58) SLC6A2SLC6A4SLC6A3HRH1PGR
Hydrochloric Acid SCHEMBL4228810 0.87 PGR (0.57) SLC6A2SLC6A4SLC6A3HRH1PGR
SCHEMBL5969784 0.82 PGR (0.53) SLC6A2SLC6A4SLC6A3HRH1PGR
SCHEMBL15575027 0.82 PGR (0.49) SLC6A2SLC6A4SLC6A3HRH1PGR
SCHEMBL15575026 0.82 PGR (0.49) SLC6A2SLC6A4SLC6A3HRH1PGR
SCHEMBL942585 0.81 SLC6A2 (0.69) SLC6A2SLC6A4SLC6A3HRH1IKBKB
SCHEMBL31128128 0.81 SLC6A2 (0.69) SLC6A2SLC6A4SLC6A3HRH1IKBKB
SCHEMBL29595595 0.80 TBK1 (0.50) HRH1PGRIKBKBROCK1ROCK2
SCHEMBL20321365 0.80 TBK1 (0.50) HRH1PGRIKBKBROCK1ROCK2
Hydrochloric Acid SCHEMBL4107468 0.80 SLC6A2 (0.67) SLC6A2SLC6A4SLC6A3HRH1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022048605-A1 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATIONS 南昌奥瑞药业有限公司 2022-03-10 WO disclosed